Skip to contentO
Odyssey Health, Inc.
O
ODYYOdyssey Health, Inc. Q4 2022 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$2.01M-$2.01MderivedN/M vs Q4 2021 EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$1,834,692N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Odyssey Health, Inc. · CIK 1626644 · Engraved from SEC EDGAR
Operating Cash Flowderived$1,080,115N/M ended Jul 31, 2022 · filed Oct 31, 2022 · 92 d after period end